The Pathophysiology Of Schizophrenia In Patients
Schizophrenia can be seen as a severe and chronic brain disorder that impacts how a person functions in the world. Individuals with schizophrenia may experience positive or psychotic symptoms like hallucinations or negative symptoms like social withdrawal, cognitive deficits, or loss of motivation. These symptoms may affect interpersonal relationships and can be challenging to manage without help from a mental health professional.
To manage schizophrenia symptoms, it may be useful to understand the pathophysiology of schizophrenia—in other words, how the disease develops. Several risk factors may lead to the development of schizophrenia, including genetic factors, abnormalities related to brain development, and changes in neurotransmitters. In addition to the biological risk factors, environmental factors may also play a role in the development of schizophrenia. A person may be diagnosed with schizophrenia when they meet the required symptoms as outlined by the Diagnostic and Statistical Manual, 5th Edition (DSM-5).
Pathophysiology of schizophrenia
Epigenetic factors and developing schizophrenia
In addition to genetic factors, it is also possible that epigenetic factors play a role in the development of schizophrenia in some individuals. Epigenetics generally refers to changes in gene expression rather than changes in the genetic code itself. Studies have shown that changes in various genetic loci and expressions may be present in individuals with schizophrenia, but more research may be needed in this area.
Neurodevelopmental factors that contribute to schizophrenia
In addition to genetic factors, neurodevelopmental factors may contribute to schizophrenia. Older research shows that schizophrenia may be linked to other neurodevelopmental disorders that can impact cognitive impairment, such as attention-deficit/hyperactivity disorder, intellectual disabilities, and autism spectrum disorder. This connection is thought to demonstrate that these mental disorders may exist on a spectrum linked by neurodevelopmental factors.
Development of psychosis during prenatal and perinatal stages
Neurodevelopmental factors connected to cognitive dysfunction may begin during prenatal and perinatal stages. During these stages, maternal infections, such as influenza, may lead to a higher rate of schizophrenia in children as they become adults. These infections can cause changes in cytokine-related inflammation, which may be attributed to inducing schizophrenia-like behaviors in adolescents and young adults.
Neuroimaging techniques have begun to uncover more in terms of how neurodevelopmental factors may cause psychotic disorders, including schizophrenia. Brain imaging studies have shown links between delayed maturation of connections in the nervous system and brain and schizophrenia, although updated evidence may be necessary. Additional studies and research into the neurodevelopmental factors may lay the groundwork for preventing schizophrenia in some people.
Neurotransmitter abnormalities affect the symptoms of schizophrenia
Neurotransmitters can be defined as chemicals that signal various functions to happen within the human body. These chemicals typically serve as messengers, sending information from one cell to another, and they allow different parts of the body to communicate. Some neurotransmitters include acetylcholine, glutamate, GABA, glycine, dopamine, norepinephrine, and serotonin.
It is believed that abnormalities in some neurotransmitters and their production levels may impact schizophrenia symptoms. Two neurotransmitters that have potential links to schizophrenia are dopamine and glutamate.
Dopamine hypothesis and positive symptoms
The dopamine hypothesis usually refers to the belief that individuals with schizophrenia may experience abnormal production of the neurotransmitter dopamine in various brain regions, including the prefrontal cortex. Studies have shown that positive schizophrenia symptoms, such as hallucinations and delusions, may be linked to the excess production of dopamine in the brain.
Dopamine hypothesis and pathophysiology of schizophrenia
In addition to excess dopamine, individuals with schizophrenia may also have a higher density of dopamine receptors, meaning that they may be more sensitive to changes in dopamine levels.
Although the dopamine hypothesis may be influential in understanding the neurobiology of schizophrenia, dopamine dysfunction may be just one of many factors contributing to the complex pathophysiology of the disorder. Other neurotransmitters, as well as environmental and structural components, may also play a role in the development of schizophrenia.
Glutamate hypothesis and negative symptoms
Another neurotransmitter that may play a role in the development of schizophrenia is glutamate. The glutamate hypothesis generally refers to the idea that glutamate levels could be higher in individuals with schizophrenia due to various interactions and receptor blockers. The increase in glutamate could serve to over-excite or overstimulate nerve cells and may be associated with negative symptoms of schizophrenia, such as social withdrawal and lack of motivation.
As a widely varied disorder, the glutamate hypothesis may hold for some individuals with schizophrenia, but not for others.
Structural and functional brain abnormalities of patients with schizophrenia
Using advanced imaging techniques, scientists have discovered that several structural brain abnormalities may contribute to the development of schizophrenia. The root of these abnormalities may lie in neural connectivity disruption that can be caused by environmental or genetic risk factors during prenatal or adolescent stages. These changes or abnormalities may lead to structural changes in the cortical or other brain regions in people with schizophrenia.
New advancements in functional neuroimaging technology have also revealed changes in gray and white matter in individuals with schizophrenia. These changes may lead to abnormalities in cognitive functioning and could impact memory, focus, and motivation.
In some individuals, these changes in brain activity can continue throughout the progression of schizophrenia. Managing schizophrenia symptoms may start by continuing to understand how the disorder impacts the brain. This can help professionals identify the disorder sooner and begin treatment before symptoms progress and intensify.
Environmental factors that contribute to psychosis
While genetic and structural factors likely play a role in the development of schizophrenia, environmental factors may also impact how the disorder develops. Environmental factors that may impact schizophrenia can include the following:
- Pregnancy and birth complications: Complications during pregnancy, such as hypoxia, influenza, premature birth, and malnutrition, may increase the chance of developing schizophrenia later in life.
- Stress: Anxiety and related stress may cause an increase in schizophrenia symptoms, such as psychosis. Older studies report that approximately 46% of individuals with a schizophrenia diagnosis experienced a stressful life event within three months of receiving their diagnosis.
- Substance use disorder: The use of some substances may trigger schizophrenia symptoms. For example, stimulants like cocaine and methamphetamine may induce psychosis in some individuals.
- Childhood trauma: Trauma during childhood, such as abuse, neglect, bullying, and other traumatic events, may play a role in the development of positive schizophrenia symptoms as an adult.
- Growing up in an urban setting: There may be an association between city living and schizophrenia, and studies show that moving from a rural environment to a city environment may substantially increase the risk of developing schizophrenia. It is unclear as to the exact mechanism for the increased rate of schizophrenia in urban areas. However, it has been hypothesized that social adversity, increased substance use, and discrimination may play a role.
As with other factors related to the pathophysiology of schizophrenia, environmental factors may be only one piece of the puzzle. With this in mind, it may be beneficial to view treating and managing schizophrenia with a holistic approach.
If you or a loved one are witnessing or experiencing any form of abuse, please know that help is available. You can call the National Domestic Violence Hotline anytime at 1-800-799-SAFE (7233).
Treatment for managing schizophrenia and related mental illness
The management of schizophrenia can be multifaceted and may require cooperation from a full team of medical and mental health professionals. In many cases, medication in the form of antipsychotics may be used in conjunction with cognitive behavioral therapy (CBT) sessions to manage symptoms and improve daily function. Always speak to your doctor before starting, stopping, or changing the way you take any form of medication.
Cognitive behavioral therapy as treatment for navigating mental illness
Online cognitive behavioral therapy techniques may be effective at treating symptoms of schizophrenia. A therapist may use a variety of techniques in an online setting to identify and manage symptoms and to provide individuals with tools and resources to manage schizophrenia. However, those experiencing acute positive or psychotic symptoms may need to seek care in person.
For individuals with schizophrenia, finding a local therapist who can meet their needs can be challenging. Online therapy generally enables individuals to choose therapists who meet their needs, even if they are not located nearby. This added flexibility can help to ensure that the client and therapist are a good fit for a long-term therapeutic relationship.
Takeaway
What is the mechanism of positive and negative symptoms in schizophrenia?
Current research on schizophrenia patients supports that positive and negative symptoms are mediated by brain dysfunction:
- Positive symptoms: It’s thought that dopamine hyperactivity in the midbrain is associated with positive symptoms, like disorganized speech, auditory hallucinations, and persecutory delusions.
- Negative symptoms: Unlike positive symptoms, negative symptoms are associated with reduced dopamine levels in the dorsolateral prefrontal cortex.
Schizophrenic patients are often prescribed antipsychotic medications for positive symptoms, as first and second-generation antipsychotics work by reducing dopamine levels in the brain. Since negative symptoms are caused by a lack of sufficient dopamine, randomized controlled trials have found that an antipsychotic medication is typically less effective. Instead, antidepressants or atypical antipsychotic formulations may be recommended.
What is the negative and positive symptoms of schizophrenia scale?
The Positive and Negative Syndrome Scale for Schizophrenia (PANSS) is a scale often used to assess and track symptoms of schizophrenia spectrum disorders. It’s often used to assess the need for antipsychotic drugs and to track treatment response over time.
How to deal with patients with schizophrenia?
Here are some strategies that can help you work with patients experiencing schizophrenia or symptoms of another psychotic disorder:
- Take a person-centered approach, practicing empathy and active listening with a nonjudgemental tone.
- Avoid accusations or confrontations.
- Use clear language.
- Speak in a calm and respectful tone.
Apathy and catatonic behavior (negative symptoms) may respond well to art therapy, cognitive behavioral therapy, and/or mood stabilizers.
What happens in the brain during schizophrenia?
Chronic schizophrenia is one of many psychiatric disorders that lead to both functional and structural brain changes. These changes include:
- Reduced function in the frontal and temporal lobes
- Structural abnormalities in glutamate receptors
- Changes in dopamine levels
- Changes in brain volume in the superior temporal gyrus
- Decreased volume of the medial temporal lobe
- Decreased synaptic density in the frontal lobe
According to the American Psychiatric Association, active phases of schizophrenia can interfere with the way the brain takes in and processes information, making it difficult for some people to distinguish what is and is not real.
Schizophrenia research into structural brain abnormalities continues to advance with technologies like diffusion tensor imaging. This research is helping improve treatment options and minimize side effects like antipsychotic-induced weight gain and fatigue.
What is the general pathophysiology of schizophrenia?
Pathophysiology is the scientific study of functional and structural changes in the body due to a disease, in this case, schizophrenia. The general pathophysiology of schizophrenia involves:
- Changes in neurotransmitter levels like dopamine, glutamate, and serotonin
- Structural brain changes to different regions, such as the basal ganglia
- Changes in brain and cerebral spinal fluid volume
There are different theories about what causes schizophrenia, with most evidence supporting the neurodevelopmental hypothesis of schizophrenia, suggesting that a clinical diagnosis is made as brain abnormalities—triggered by genetic and environmental factors—develop and mature.
What is the pathophysiologic basis of schizophrenia?
The pathophysiologic basis of schizophrenia is thought to originate from central nervous system abnormalities, including changes in dopamine and glutamate activity, and structural brain changes. This can lead to changes in cognitive function (like working memory, problem-solving, and occupational functioning), delusions, social isolation, and low motivation.
Schizophrenia compared to other psychiatric disorders, like bipolar disorder and major depressive disorder, is primarily differentiated by dopamine imbalances. Specifically, symptoms of schizophrenia are associated with widespread dopamine changes (low in the prefrontal cortex and high in the mesolimbic system), whereas major depressive or bipolar disorder in a depressive phase is associated with low dopamine levels. In bipolar disorder, dopamine can oscillate between high (manic or hypomanic) and low levels (depressive phase).
What is the pathophysiology of schizophrenia affective disorder?
According to the Diagnostic and Statistical Manual, Fifth Edition (DSM-5), schizophrenia is made based on the following criteria:
- At least two of the following symptoms in one month, with at least one being delusions hallucinations, or disorganized speech: Delusions, hallucinations, disorganized speech, catatonic behavior or serious disorganization, or negative symptoms.
- Background: Schizophrenia symptoms must persist for at least one month, with six months or more of signs indicating disturbance.
- Impact to the level of daily functioning.
- Other possible diagnoses, like schizoaffective disorder or schizotypal personality disorder, have been ruled out.
Current research on schizophrenia disorders suggests that the origin of schizophrenia involves changes in early brain development (called the neurodevelopment hypothesis). This theory of schizophrenia suggests that cognitive symptoms develop in early adulthood because of environmental and genetic triggers impacting the brain during important developmental stages.
What is the psychopathology of schizophrenia?
The psychopathology of schizophrenia refers to the unique signs and symptoms of the disorder. For example, people with schizophrenia may experience delusions, hallucinations, disorganized thoughts, apathy, social withdrawal, agitation, and challenges with cognitive functioning.
Schizophrenia symptom severity is impacted by things like substance use, treatment quality, stressors, life experiences, and access to a support system.
What is the physiological explanation of schizophrenia?
The physiology of schizophrenia includes complex interactions between environmental factors and genetics that lead to an increased risk of schizophrenia development. Much of the current research focuses on differences in neurotransmitters (primarily dopamine and glutamate) which are dysregulated in people with schizophrenia, contributing to symptoms like psychosis and apathy. Treatments like antipsychotics often target these neurotransmitters to manage symptoms.
What is the pathology of schizophrenia in the brain?
From a pathological perspective, schizophrenia is characterized by significant changes in brain structure and function, including changes in synaptic density, brain volume, ventricle size, and neurotransmitter activity. Many randomized clinical trials focus on these pathological changes for potential advancement in treatment.
- Previous Article
- Next Article